Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Updated: Apr 27, 2026
Travis Steed's Stock Ratings
B of A Securities Analyst
Travis Steed is an analyst at B of A Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.
Overall Average Return
5.76%
Smart Score
Overall Average Return Percentile
47th
Number of Ratings
66
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 04/17/2026 | ABT | Buy Now | Abbott Laboratories | $93.15 | 28.82% | $150 → $120 | Maintains | Buy | Get Alert | |
| 03/31/2026 | MMED | Buy Now | Minimed Group | $12.92 | 108.98% | → $27 | Initiates | → Buy | Get Alert | |
| 02/20/2026 | TNDM | Buy Now | Tandem Diabetes Care | $19.75 | 51.9% | $15 → $30 | Upgrade | Underperform → Neutral | Get Alert | |
| 01/05/2026 | BBNX | Buy Now | Beta Bionics | $10.66 | 209.57% | $30 → $33 | Maintains | Buy | Get Alert | |
| 01/05/2026 | PEN | Buy Now | Penumbra | $327.98 | 12.81% | $320 → $370 | Maintains | Buy | Get Alert | |
| 01/05/2026 | BDX | Buy Now | Becton Dickinson | $150.22 | 37.8% | $190 → $207 | Maintains | Neutral | Get Alert | |
| 12/08/2025 | CNMD | Buy Now | Conmed | $37.87 | 37.31% | $65 → $52 | Maintains | Neutral | Get Alert | |
| 11/17/2025 | MASI | Buy Now | Masimo | $178.66 | -9.32% | → $162 | Initiates | → Neutral | Get Alert | |
| 04/07/2025 | BDX | Buy Now | Becton Dickinson | $150.22 | 73.75% | $279 → $261 | Maintains | Overweight | Get Alert | |
| 03/14/2025 | PEN | Buy Now | Penumbra | $327.98 | -2.43% | → $320 | Initiates | → Buy | Get Alert | |
| 03/10/2025 | ABT | Buy Now | Abbott Laboratories | $93.15 | 61.03% | $133 → $150 | Maintains | Buy | Get Alert | |
| 02/26/2025 | SOLV | Buy Now | Solventum | $69.78 | 21.81% | $80 → $85 | Maintains | Neutral | Get Alert | |
| 02/14/2025 | BDX | Buy Now | Becton Dickinson | $150.22 | 85.73% | $278 → $279 | Maintains | Overweight | Get Alert | |
| 01/22/2025 | BDX | Buy Now | Becton Dickinson | $150.22 | 85.06% | $312 → $278 | Maintains | Overweight | Get Alert | |
| 12/16/2024 | EW | Buy Now | Edwards Lifesciences | $83.46 | 7.84% | $82 → $90 | Upgrade | Neutral → Buy | Get Alert | |
| 11/05/2024 | CBLL | Buy Now | CeriBell | $21.14 | 51.37% | → $32 | Initiates | → Buy | Get Alert | |
| 07/25/2024 | EW | Buy Now | Edwards Lifesciences | $83.46 | -10.14% | $105 → $75 | Downgrade | Buy → Neutral | Get Alert | |
| 06/25/2024 | SOLV | Buy Now | Solventum | $69.78 | -14.02% | $70 → $60 | Maintains | Neutral | Get Alert | |
| 05/10/2024 | SOLV | Buy Now | Solventum | $69.78 | 0.32% | → $70 | Initiates | → Neutral | Get Alert | |
| 05/06/2024 | BDX | Buy Now | Becton Dickinson | $150.22 | 107.7% | $305 → $312 | Maintains | Overweight | Get Alert | |
| 03/07/2024 | EW | Buy Now | Edwards Lifesciences | $83.46 | — | — | Upgrade | Neutral → Buy | Get Alert | |
| 03/05/2024 | BAX | Buy Now | Baxter Intl | $18.49 | 143.37% | $42 → $45 | Maintains | Neutral | Get Alert | |
| 02/05/2024 | BDX | Buy Now | Becton Dickinson | $150.22 | 103.04% | $301 → $305 | Maintains | Overweight | Get Alert | |
| 10/13/2023 | OM | Buy Now | Outset Medical | $4.60 | -34.78% | $32 → $3 | Downgrade | Buy → Underperform | Get Alert | |
| 09/05/2023 | SYK | Buy Now | Stryker | $329.01 | -4.26% | → $315 | Upgrade | Neutral → Buy | Get Alert | |
| 08/24/2023 | PODD | Buy Now | Insulet | $187.67 | 57.19% | $365 → $295 | Maintains | Buy | Get Alert | |
| 08/22/2023 | AXGN | Buy Now | Axogen | $39.39 | -59.38% | → $16 | Reiterates | Overweight → Overweight | Get Alert | |
| 08/07/2023 | BDX | Buy Now | Becton, Dickinson | $150.22 | 101.7% | $284 → $303 | Maintains | Overweight | Get Alert | |
| 07/12/2023 | SILK | Buy Now | Silk Road Medical | — | — | $51 → $28 | Downgrade | Buy → Underperform | Get Alert | |
| 05/08/2023 | BDX | Buy Now | Becton, Dickinson | $150.22 | 89.06% | $282 → $284 | Maintains | Overweight | Get Alert | |
| 05/05/2023 | TNDM | Buy Now | Tandem Diabetes Care | $19.75 | 67.09% | $45 → $33 | Downgrade | Neutral → Underperform | Get Alert | |
| 05/03/2023 | ZBH | Buy Now | Zimmer Biomet Holdings | $92.59 | 72.8% | $120 → $160 | Upgrade | Underperform → Neutral | Get Alert | |
| 04/19/2023 | ISRG | Buy Now | Intuitive Surgical | $471.10 | -33.14% | $300 → $315 | Maintains | Buy | Get Alert | |
| 04/11/2023 | SWAV | Buy Now | ShockWave Medical | — | — | $235 → $275 | Maintains | Buy | Get Alert | |
| 01/03/2023 | BDX | Buy Now | Becton, Dickinson | $150.22 | 93.05% | $250 → $290 | Upgrade | Neutral → Buy | Get Alert | |
| 01/03/2023 | LUNG | Buy Now | Pulmonx | $1.26 | 534.92% | → $8 | Downgrade | Neutral → Underperform | Get Alert | |
| 01/03/2023 | BAX | Buy Now | Baxter Intl | $18.49 | 197.46% | → $55 | Downgrade | Buy → Neutral | Get Alert | |
| 07/11/2022 | SYK | Buy Now | Stryker | $329.01 | -34.65% | → $215 | Downgrade | Buy → Neutral | Get Alert | |
| 06/21/2022 | EMBC | Buy Now | Embecta | $9.24 | 170.56% | → $25 | Initiates | → Underperform | Get Alert | |
| 05/31/2022 | ABT | Buy Now | Abbott Laboratories | $93.15 | 50.3% | $140 → $140 | Maintains | Buy | Get Alert | |
| 03/02/2022 | PODD | Buy Now | Insulet | $187.67 | — | — | Reinstates | → Buy | Get Alert | |
| 03/02/2022 | ABT | Buy Now | Abbott Laboratories | $93.15 | 50.3% | → $140 | Reinstates | → Buy | Get Alert | |
| 10/13/2021 | INMD | Buy Now | InMode | $14.39 | 490.69% | $120 → $85 | Maintains | Overweight | Get Alert | |
| 10/05/2021 | ZBH | Buy Now | Zimmer Biomet Holdings | $92.59 | 100.89% | $210 → $186 | Maintains | Overweight | Get Alert | |
| 09/03/2021 | BAX | Buy Now | Baxter Intl | $18.49 | 440.83% | $93 → $100 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 07/13/2021 | INMD | Buy Now | InMode | $14.39 | 733.91% | $92 → $120 | Maintains | Overweight | Get Alert | |
| 07/12/2021 | AXNX | Buy Now | Axonics | — | — | → $74 | Initiates | → Overweight | Get Alert | |
| 06/02/2021 | ABT | Buy Now | Abbott Laboratories | $93.15 | 34.19% | $150 → $125 | Maintains | Overweight | Get Alert | |
| 05/25/2021 | DXCM | Buy Now | DexCom | $61.41 | 714.2% | → $500 | Initiates | → Overweight | Get Alert | |
| 05/25/2021 | CSII | Buy Now | Cardiovascular Systems | — | — | — | Initiates | → Equal-Weight | Get Alert | |
| 05/25/2021 | BAX | Buy Now | Baxter Intl | $18.49 | 402.97% | → $93 | Initiates | → Equal-Weight | Get Alert | |
| 05/25/2021 | BDX | Buy Now | Becton, Dickinson | $150.22 | 79.74% | → $270 | Initiates | → Equal-Weight | Get Alert | |
| 05/25/2021 | MDT | Buy Now | Medtronic | $83.11 | 74.47% | → $145 | Initiates | → Equal-Weight | Get Alert | |
| 05/25/2021 | ABT | Buy Now | Abbott Laboratories | $93.15 | 61.03% | → $150 | Initiates | → Overweight | Get Alert | |
| 05/25/2021 | BSX | Buy Now | Boston Scientific | $60.22 | -15.31% | → $51 | Initiates | → Overweight | Get Alert | |
| 05/25/2021 | EW | Buy Now | Edwards Lifesciences | $83.46 | 31.8% | → $110 | Initiates | → Overweight | Get Alert | |
| 05/25/2021 | PODD | Buy Now | Insulet | $187.67 | 59.86% | → $300 | Initiates | → Overweight | Get Alert | |
| 05/25/2021 | CNMD | Buy Now | Conmed | $37.87 | 362.11% | → $175 | Initiates | → Overweight | Get Alert | |
| 05/25/2021 | INMD | Buy Now | InMode | $14.39 | 539.33% | → $92 | Initiates | → Overweight | Get Alert | |
| 05/25/2021 | SYK | Buy Now | Stryker | $329.01 | -14.9% | → $280 | Initiates | → Underweight | Get Alert | |
| 05/25/2021 | TNDM | Buy Now | Tandem Diabetes Care | $19.75 | 355.7% | → $90 | Initiates | → Underweight | Get Alert | |
| 05/25/2021 | ZBH | Buy Now | Zimmer Biomet Holdings | $92.59 | 126.81% | → $210 | Initiates | → Overweight | Get Alert | |
| 06/17/2020 | DXCM | Buy Now | DexCom | $61.41 | 714.2% | $375 → $500 | Maintains | Buy | Get Alert | |
| 12/18/2019 | DXCM | Buy Now | DexCom | $61.41 | 307.1% | $220 → $250 | Reiterates | → Buy | Get Alert | |
| 11/07/2019 | AXGN | Buy Now | Axogen | $39.39 | -51.76% | $21 → $19 | Maintains | Overweight | Get Alert | |
| 09/03/2019 | BSX | Buy Now | Boston Scientific | $60.22 | -20.29% | → $48 | Reinstates | → Overweight | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved